{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:39:27Z","timestamp":1779183567487,"version":"3.51.4"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI11\/00016"],"award-info":[{"award-number":["FI11\/00016"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI11\/01609"],"award-info":[{"award-number":["PI11\/01609"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00524"],"award-info":[{"award-number":["PI17\/00524"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00553"],"award-info":[{"award-number":["PI19\/00553"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013816","name":"Departament d'Empresa i Coneixement, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2014-SGR338"],"award-info":[{"award-number":["2014-SGR338"]}],"id":[{"id":"10.13039\/501100013816","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013816","name":"Departament d'Empresa i Coneixement, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2017-SGR-496"],"award-info":[{"award-number":["2017-SGR-496"]}],"id":[{"id":"10.13039\/501100013816","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neurofibromatosis Type 1 (NF1) is a genetic condition affecting approximately 1:3500 persons worldwide. The <jats:italic>NF1<\/jats:italic> gene codes for neurofibromin protein, a GTPase activating protein (GAP) and a negative regulator of RAS. The <jats:italic>NF1<\/jats:italic> gene undergoes alternative splicing of exon 23a (E23a) that codes for 21 amino acids placed at the center of the GAP related domain (GRD). E23a-containing type II neurofibromin exhibits a weaker Ras-GAP activity compared to E23a-less type I isoform. Exon E23a has been related with the cognitive impairment present in NF1 individuals. We designed antisense Phosphorodiamidate Morpholino Oligomers (PMOs) to modulate E23a alternative splicing at physiological conditions of gene expression and tested their impact during PC12 cell line neuronal differentiation. Results show that any dynamic modification of the natural ratio between type I and type II isoforms disturbed neuronal differentiation, altering the proper formation of neurites and deregulating both the MAPK\/ERK and cAMP\/PKA signaling pathways. Our results suggest an opposite regulation of these pathways by neurofibromin and the possible existence of a feedback loop sensing neurofibromin-related signaling. The present work illustrates the utility of PMOs to study alternative splicing that could be applied to other alternatively spliced genes in vitro and in vivo.<\/jats:p>","DOI":"10.1038\/s41598-021-83152-w","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T11:03:58Z","timestamp":1613041438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation"],"prefix":"10.1038","volume":"11","author":[{"given":"Josep","family":"Biayna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Mazuelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernat","family":"Gel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest","family":"Terribas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrijela","family":"Dumbovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inma","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juana","family":"Fern\u00e1ndez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Castellanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meritxell","family":"Carri\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conxi","family":"Lazaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"83152_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/jmg.2006.045906","volume":"44","author":"RE Ferner","year":"2007","unstructured":"Ferner, R. E. et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J. Med. Genet. 44, 81\u201388 (2007).","journal-title":"J. Med. Genet."},{"key":"83152_CR2","first-page":"39","volume-title":"Neurofibromatosis Type 1 from Genotype to Phenotype","author":"D Viskochil","year":"1998","unstructured":"Viskochil, D. Gene structure and expression. In Neurofibromatosis Type 1 from Genotype to Phenotype (eds Upadhyaya, M. & Cooper, D. N.) 39\u201356 (Bios Scientific, Milton Park, 1998)."},{"key":"83152_CR3","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/hmg\/4.5.915","volume":"4","author":"G Danglot","year":"1995","unstructured":"Danglot, G. et al. Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5\u2019 part of the gene. Hum. Mol. Genet. 4, 915\u2013920 (1995).","journal-title":"Hum. Mol. Genet."},{"key":"83152_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/jnr.490360212","volume":"36","author":"DH Gutmann","year":"1993","unstructured":"Gutmann, D. H., Tennekoon, G. I., Cole, J. L., Collins, F. S. & Rutkowski, J. L. Modulation of the neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation. J. Neurosci. Res. 36, 216\u2013223 (1993).","journal-title":"J. Neurosci. Res."},{"key":"83152_CR5","first-page":"1555","volume":"6","author":"T Nishi","year":"1991","unstructured":"Nishi, T. et al. Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation. Oncogene 6, 1555\u20131559 (1991).","journal-title":"Oncogene"},{"key":"83152_CR6","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/0092-8674(90)90151-4","volume":"63","author":"R Ballester","year":"1990","unstructured":"Ballester, R. et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63, 851\u2013859 (1990).","journal-title":"Cell"},{"key":"83152_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(90)90150-D","volume":"63","author":"GA Martin","year":"1990","unstructured":"Martin, G. A. et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63, 843\u2013849 (1990).","journal-title":"Cell"},{"key":"83152_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","volume":"62","author":"GF Xu","year":"1990","unstructured":"Xu, G. F. et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62, 599\u2013608 (1990).","journal-title":"Cell"},{"key":"83152_CR9","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/351576a0","volume":"351","author":"G Bollag","year":"1991","unstructured":"Bollag, G. & McCormick, F. Differential regulation of rasGAP and neurofibromatosis gene product activities. Nature 351, 576\u2013579 (1991).","journal-title":"Nature"},{"key":"83152_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1515\/hsz-2015-0270","volume":"397","author":"J Zhong","year":"2016","unstructured":"Zhong, J. RAS and downstream RAF-MEK and PI3K-AKT signaling in neuronal development, function and dysfunction. Biol. Chem. 397, 215\u2013222 (2016).","journal-title":"Biol. Chem."},{"key":"83152_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/nar\/gkp766","volume":"38","author":"VA Barron","year":"2010","unstructured":"Barron, V. A., Zhu, H., Hinman, M. N., Ladd, A. N. & Lou, H. The neurofibromatosis type I pre-mRNA is a novel target of CELF protein-mediated splicing regulation. Nucleic Acids Res. 38, 253\u2013264 (2010).","journal-title":"Nucleic Acids Res."},{"key":"83152_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2199-13-35","volume":"13","author":"VA Fleming","year":"2012","unstructured":"Fleming, V. A., Geng, C., Ladd, A. N. & Lou, H. Alternative splicing of the neurofibromatosis type 1 pre-mRNA is regulated by the muscleblind-like proteins and the CUG-BP and ELAV-like factors. BMC Mol. Biol. 13, 35 (2012).","journal-title":"BMC Mol. Biol."},{"key":"83152_CR13","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1128\/MCB.01509-07","volume":"28","author":"H Zhu","year":"2008","unstructured":"Zhu, H., Hinman, M. N., Hasman, R. A., Mehta, P. & Lou, H. Regulation of neuron-specific alternative splicing of neurofibromatosis type 1 pre-mRNA. Mol. Cell. Biol. 28, 1240\u20131251 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"83152_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0006-291X(05)81497-4","volume":"187","author":"T Uchida","year":"1992","unstructured":"Uchida, T. et al. Expression of two types of neurofibromatosis type 1 gene transcripts in gastric cancers and comparison of GAP activities. Biochem. Biophys. Res. Commun. 187, 332\u2013339 (1992).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"83152_CR15","doi-asserted-by":"publisher","first-page":"26958","DOI":"10.1074\/jbc.M209413200","volume":"278","author":"S Yunoue","year":"2003","unstructured":"Yunoue, S. et al. Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras. J. Biol. Chem. 278, 26958\u201326969 (2003).","journal-title":"J. Biol. Chem."},{"key":"83152_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/MCB.13.1.487","volume":"13","author":"LB Andersen","year":"1993","unstructured":"Andersen, L. B. et al. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol. Cell. Biol. 13, 487\u2013495 (1993).","journal-title":"Mol. Cell. Biol."},{"key":"83152_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tig.2013.04.003","volume":"29","author":"S Zheng","year":"2013","unstructured":"Zheng, S. & Black, D. L. Alternative pre-mRNA splicing in neurons: growing up and extending its reach. Trends Genet. 29, 442\u2013448 (2013).","journal-title":"Trends Genet."},{"key":"83152_CR18","doi-asserted-by":"publisher","first-page":"e1585","DOI":"10.1002\/wrna.1585","volume":"11","author":"S Zheng","year":"2020","unstructured":"Zheng, S. Alternative splicing programming of axon formation. Wiley Interdiscip. Rev. RNA 11, e1585 (2020).","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"83152_CR19","first-page":"315","volume":"6","author":"DH Gutmann","year":"1995","unstructured":"Gutmann, D. H., Geist, R. T., Wright, D. E. & Snider, W. D. Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues. Cell Growth Differ. 6, 315\u2013323 (1995).","journal-title":"Cell Growth Differ."},{"key":"83152_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/mc.2940060203","volume":"6","author":"H Mochizuki","year":"1992","unstructured":"Mochizuki, H. et al. Alternative splicing of neurofibromatosis type 1 gene transcript in malignant brain tumors: PCR analysis of frozen-section mRNA. Mol. Carcinog. 6, 83\u201387 (1992).","journal-title":"Mol. Carcinog."},{"key":"83152_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/BF00373420","volume":"287","author":"I Eisenbarth","year":"1995","unstructured":"Eisenbarth, I., Hoffmeyer, S., Kaufmann, D., Assum, G. & Krone, W. Analysis of an alternatively spliced exon of the neurofibromatosis type 1 gene in cultured melanocytes from patients with neurofibromatosis 1. Arch. Dermatol. Res. 287, 413\u2013416 (1995).","journal-title":"Arch. Dermatol. Res."},{"key":"83152_CR22","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1023\/A:1006905224474","volume":"27","author":"O Hirvonen","year":"1998","unstructured":"Hirvonen, O. et al. Developmental regulation of NF1 tumor suppressor gene in human peripheral nerve. J. Neurocytol. 27, 939\u2013952 (1998).","journal-title":"J. Neurocytol."},{"key":"83152_CR23","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1006\/dbio.1994.1052","volume":"161","author":"DP Huynh","year":"1994","unstructured":"Huynh, D. P., Nechiporuk, T. & Pulst, S. M. Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development. Dev. Biol. 161, 538\u2013551 (1994).","journal-title":"Dev. Biol."},{"key":"83152_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0753-3322(94)90053-1","volume":"48","author":"G Danglot","year":"1994","unstructured":"Danglot, G., Teinturier, C., Duverger, A. & Bernheim, A. Tissue-specific alternative splicing of neurofibromatosis 1 (NF1) mRNA. Biomed. Pharmacother. 48, 365\u2013372 (1994).","journal-title":"Biomed. Pharmacother."},{"key":"83152_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1042\/cs0870481","volume":"87","author":"K Takahashi","year":"1994","unstructured":"Takahashi, K. et al. Multiple transcripts of the neurofibromatosis type 1 gene in human brain and in brain tumours. Clin. Sci. (Lond) 87, 481\u2013485 (1994).","journal-title":"Clin. Sci. (Lond)"},{"key":"83152_CR26","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/0006-291X(91)92029-J","volume":"181","author":"Y Suzuki","year":"1991","unstructured":"Suzuki, Y., Suzuki, H., Kayama, T., Yoshimoto, T. & Shibahara, S. Brain tumors predominantly express the neurofibromatosis type 1 gene transcripts containing the 63 base insert in the region coding for GTPase activating protein-related domain. Biochem. Biophys. Res. Commun. 181, 955\u2013961 (1991).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"83152_CR27","first-page":"1","volume":"2018","author":"X Guo","year":"2018","unstructured":"Guo, X. et al. Quantitative analysis of alternative pre-mRNA splicing in mouse brain sections using RNA in situ hybridization assay. J. Vis. Exp. 2018, 1\u20138 (2018).","journal-title":"J. Vis. Exp."},{"key":"83152_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1006\/excr.1996.0297","volume":"228","author":"LJ Metheny","year":"1996","unstructured":"Metheny, L. J. & Skuse, G. R. NF1 mRNA isoform expression in PC12 cells: modulation by extrinsic factors. Exp. Cell Res. 228, 44\u201349 (1996).","journal-title":"Exp. Cell Res."},{"key":"83152_CR29","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1128\/MCB.00019-14","volume":"34","author":"MN Hinman","year":"2014","unstructured":"Hinman, M. N., Sharma, A., Luo, G. & Lou, H. Neurofibromatosis type 1 alternative splicing is a key regulator of ras signaling in neurons. Mol. Cell. Biol. 34, 2188\u20132197 (2014).","journal-title":"Mol. Cell. Biol."},{"key":"83152_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nn792","volume":"5","author":"J Tong","year":"2002","unstructured":"Tong, J., Hannan, F., Zhu, Y., Bernards, A. & Zhong, Y. Neurofibromin regulates G protein-stimulated adenylyl cyclase activity. Nat. Neurosci. 5, 95\u201396 (2002).","journal-title":"Nat. Neurosci."},{"key":"83152_CR31","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1126\/science.276.5313.795","volume":"276","author":"HF Guo","year":"1997","unstructured":"Guo, H. F., The, I., Hannan, F., Bernards, A. & Zhong, Y. Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. Science 276, 795\u2013798 (1997).","journal-title":"Science"},{"key":"83152_CR32","doi-asserted-by":"publisher","first-page":"pe15","DOI":"10.1126\/stke.3822007pe15","volume":"2007","author":"MJ Gerdin","year":"2007","unstructured":"Gerdin, M. J. & Eiden, L. E. Regulation of PC12 cell differentiation by cAMP signaling to ERK independent of PKA: do all the connections add up?. Sci. STKE 2007, pe15 (2007).","journal-title":"Sci. STKE"},{"key":"83152_CR33","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1111\/j.1742-4658.2005.04763.x","volume":"272","author":"N Dumaz","year":"2005","unstructured":"Dumaz, N. & Marais, R. Integrating signals between cAMP and the RAS\/RAF\/MEK\/ERK signalling pathways. Based on The Anniversary Prize of the Gesellschaft fur Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels. FEBS J. 272, 3491\u20133504 (2005).","journal-title":"FEBS J."},{"key":"83152_CR34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0962-8924(02)02294-8","volume":"12","author":"PJS Stork","year":"2002","unstructured":"Stork, P. J. S. & Schmitt, J. M. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 12, 258\u2013266 (2002).","journal-title":"Trends Cell Biol."},{"key":"83152_CR35","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/86898","volume":"27","author":"RM Costa","year":"2001","unstructured":"Costa, R. M. et al. Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1. Nat. Genet. 27, 399\u2013405 (2001).","journal-title":"Nat. Genet."},{"key":"83152_CR36","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1093\/hmg\/ddx264","volume":"26","author":"HT Nguyen","year":"2017","unstructured":"Nguyen, H. T. et al. Neurofibromatosis type 1 alternative splicing is a key regulator of Ras\/ERK signaling and learning behaviors in mice. Hum. Mol. Genet. 26, 3797\u20133807 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"83152_CR37","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/35002593","volume":"403","author":"HF Guo","year":"2000","unstructured":"Guo, H. F., Tong, J., Hannan, F., Luo, L. & Zhong, Y. A neurofibromatosis-1-regulated pathway is required for learning in Drosophila. Nature 403, 895\u2013898 (2000).","journal-title":"Nature"},{"key":"83152_CR38","doi-asserted-by":"publisher","first-page":"8673","DOI":"10.1073\/pnas.90.18.8673","volume":"90","author":"Z Dominski","year":"1993","unstructured":"Dominski, Z. & Kole, R. Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 90, 8673\u20138677 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"83152_CR39","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/sj.gt.3302800","volume":"13","author":"G McClorey","year":"2006","unstructured":"McClorey, G., Moulton, H. M., Iversen, P. L., Fletcher, S. & Wilton, S. D. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. Gene Ther. 13, 1373\u20131381 (2006).","journal-title":"Gene Ther."},{"key":"83152_CR40","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.ymthe.2019.07.012","volume":"27","author":"Y Echigoya","year":"2019","unstructured":"Echigoya, Y. et al. Exons 45\u201355 skipping using mutation-tailored cocktails of antisense morpholinos in the DMD gene. Mol. Ther. 27, 2005\u20132017 (2019).","journal-title":"Mol. Ther."},{"key":"83152_CR41","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nm1204","volume":"11","author":"P Scaffidi","year":"2005","unstructured":"Scaffidi, P. & Misteli, T. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat. Med. 11, 440\u2013445 (2005).","journal-title":"Nat. Med."},{"key":"83152_CR42","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/ejhg.2012.261","volume":"21","author":"E Castellanos","year":"2013","unstructured":"Castellanos, E. et al. In vitro antisense therapeutics for a deep intronic mutation causing Neurofibromatosis type 2. Eur. J. Hum. Genet. 21, 769\u2013773 (2013).","journal-title":"Eur. J. Hum. Genet."},{"key":"83152_CR43","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/humu.20933","volume":"30","author":"E Pros","year":"2009","unstructured":"Pros, E. et al. Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations. Hum. Mutat. 30, 454\u2013462 (2009).","journal-title":"Hum. Mutat."},{"key":"83152_CR44","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/humu.21500","volume":"32","author":"J Fern\u00e1ndez-Rodr\u00edguez","year":"2011","unstructured":"Fern\u00e1ndez-Rodr\u00edguez, J. et al. A mild neurofibromatosis type 1 phenotype produced by the combination of the benign nature of a leaky NF1-splice mutation and the presence of a complex mosaicism. Hum. Mutat. 32, 705\u2013709 (2011).","journal-title":"Hum. Mutat."},{"key":"83152_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ydbio.2014.06.026","volume":"393","author":"D Schnerwitzki","year":"2014","unstructured":"Schnerwitzki, D. et al. Alternative splicing of Wilms tumor suppressor 1 (Wt1) exon 4 results in protein isoforms with different functions. Dev. Biol. 393, 24\u201332 (2014).","journal-title":"Dev. Biol."},{"key":"83152_CR46","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1038\/jid.2009.83","volume":"129","author":"J-J Shieh","year":"2009","unstructured":"Shieh, J.-J., Liu, K.-T., Huang, S.-W., Chen, Y.-J. & Hsieh, T.-Y. Modification of alternative splicing of Mcl-1 pre-mRNA using antisense morpholino oligonucleotides induces apoptosis in basal cell carcinoma cells. J. Invest. Dermatol. 129, 2497\u20132506 (2009).","journal-title":"J. Invest. Dermatol."},{"key":"83152_CR47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-4939-7204-3_4","volume":"1648","author":"JE Park","year":"2017","unstructured":"Park, J. E. & Cartegni, L. In vitro modulation of endogenous alternative splicing using splice-switching antisense oligonucleotides. Methods Mol. Biol. 1648, 39\u201352 (2017).","journal-title":"Methods Mol. Biol."},{"key":"83152_CR48","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1093\/nar\/29.19.3965","volume":"29","author":"P Sazani","year":"2001","unstructured":"Sazani, P. et al. Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs. Nucleic Acids Res. 29, 3965\u20133974 (2001).","journal-title":"Nucleic Acids Res."},{"key":"83152_CR49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/gene.1039","volume":"30","author":"PA Morcos","year":"2001","unstructured":"Morcos, P. A. Achieving efficient delivery of morpholino oligos in cultured cells. Genesis 30, 94\u2013102 (2001).","journal-title":"Genesis"},{"key":"83152_CR50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1196\/annals.1359.012","volume":"1058","author":"JE Summerton","year":"2005","unstructured":"Summerton, J. E. Endo-Porter: a novel reagent for safe, effective delivery of substances into cells. Ann. N. Y. Acad. Sci. 1058, 62\u201375 (2005).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"83152_CR51","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1073\/pnas.73.7.2424","volume":"73","author":"LA Greene","year":"1976","unstructured":"Greene, L. A. & Tischler, A. S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73, 2424\u20132428 (1976).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"83152_CR52","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ntt.2004.02.006","volume":"26","author":"KP Das","year":"1996","unstructured":"Das, K. P., Freudenrich, T. M. & Mundy, W. R. Assessment of PC12 cell differentiation and neurite growth: a comparison of morphological and neurochemical measures. Neurotoxicol. Teratol. 26, 397\u2013406 (1996).","journal-title":"Neurotoxicol. Teratol."},{"key":"83152_CR53","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/sj.ejhg.5201098","volume":"12","author":"D Kaufmann","year":"2004","unstructured":"Kaufmann, D., Kenner, O., Nurnberg, P., Vogel, W. & Bartelt, B. In NF1, CFTR, PER3, CARS and SYT7, alternatively included exons show higher conservation of surrounding intron sequences than constitutive exons. Eur. J. Hum. Genet. 12, 139\u2013149 (2004).","journal-title":"Eur. J. Hum. Genet."},{"key":"83152_CR54","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1371\/journal.pcbi.0020004","volume":"2","author":"CW Sugnet","year":"2006","unstructured":"Sugnet, C. W. et al. Unusual intron conservation near tissue-regulated exons found by splicing microarrays. PLoS Comput. Biol. 2, e4 (2006).","journal-title":"PLoS Comput. Biol."},{"key":"83152_CR55","doi-asserted-by":"publisher","first-page":"e2806","DOI":"10.1371\/journal.pone.0002806","volume":"3","author":"L Chen","year":"2008","unstructured":"Chen, L. & Zheng, S. Identify alternative splicing events based on position-specific evolutionary conservation. PLoS ONE 3, e2806 (2008).","journal-title":"PLoS ONE"},{"key":"83152_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1101\/gr.119834.110","volume":"22","author":"S Gelfman","year":"2012","unstructured":"Gelfman, S. et al. Changes in exon-intron structure during vertebrate evolution affect the splicing pattern of exons. Genome Res. 22, 35\u201350 (2012).","journal-title":"Genome Res."},{"key":"83152_CR57","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1093\/hmg\/ddh272","volume":"13","author":"IG Bruno","year":"2004","unstructured":"Bruno, I. G., Jin, W. & Cote, G. J. Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements. Hum. Mol. Genet. 13, 2409\u20132420 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"83152_CR58","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1089\/hum.2012.211","volume":"24","author":"H Zhou","year":"2013","unstructured":"Zhou, H. et al. A novel morpholino oligomer targeting ISS-N1 improves rescue of severe spinal muscular atrophy transgenic mice. Hum. Gene Ther. 24, 331\u2013342 (2013).","journal-title":"Hum. Gene Ther."},{"key":"83152_CR59","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1128\/JVI.01708-10","volume":"85","author":"W Guan","year":"2011","unstructured":"Guan, W., Cheng, F., Huang, Q., Kleiboeker, S. & Qiu, J. Inclusion of the central exon of parvovirus B19 precursor mRNA is determined by multiple splicing enhancers in both the exon and the downstream intron. J. Virol. 85, 2463\u20132468 (2011).","journal-title":"J. Virol."},{"key":"83152_CR60","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1042\/BSR20110060","volume":"32","author":"VA Barron","year":"2012","unstructured":"Barron, V. A. & Lou, H. Alternative splicing of the neurofibromatosis type I pre-mRNA. Biosci. Rep. 32, 131\u2013138 (2012).","journal-title":"Biosci. Rep."},{"key":"83152_CR61","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1126\/science.1071552","volume":"296","author":"D Vaudry","year":"2002","unstructured":"Vaudry, D., Stork, P. J. S., Lazarovici, P. & Eiden, L. E. Signaling pathways for PC12 cell differentiation: making the right connections. Science 296, 1648\u20131649 (2002).","journal-title":"Science"},{"key":"83152_CR62","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0092-8674(95)90401-8","volume":"80","author":"CJ Marshall","year":"1995","unstructured":"Marshall, C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179\u2013185 (1995).","journal-title":"Cell"},{"key":"83152_CR63","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrc3911","volume":"15","author":"N Ratner","year":"2015","unstructured":"Ratner, N. & Miller, S. J. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat. Rev. Cancer 15, 290\u2013301 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"83152_CR64","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/ng0397-281","volume":"15","author":"AJ Silva","year":"1997","unstructured":"Silva, A. J. et al. A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat. Genet. 15, 281\u2013284 (1997).","journal-title":"Nat. Genet."},{"key":"83152_CR65","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nature711","volume":"415","author":"RM Costa","year":"2002","unstructured":"Costa, R. M. et al. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 415, 526\u2013530 (2002).","journal-title":"Nature"},{"key":"83152_CR66","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cell.2008.09.060","volume":"135","author":"Y Cui","year":"2008","unstructured":"Cui, Y. et al. Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell 135, 549\u2013560 (2008).","journal-title":"Cell"},{"key":"83152_CR67","doi-asserted-by":"publisher","first-page":"e61472","DOI":"10.1371\/journal.pone.0061472","volume":"8","author":"DP Ferguson","year":"2013","unstructured":"Ferguson, D. P., Schmitt, E. E. & Lightfoot, J. T. Vivo-morpholinos induced transient knockdown of physical activity related proteins. PLoS ONE 8, e61472 (2013).","journal-title":"PLoS ONE"},{"key":"83152_CR68","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1089\/nat.2016.0652","volume":"27","author":"F Shabanpoor","year":"2017","unstructured":"Shabanpoor, F. et al. Identification of a peptide for systemic brain delivery of a morpholino oligonucleotide in mouse models of spinal muscular atrophy. Nucleic Acid Ther. 27, 130\u2013143 (2017).","journal-title":"Nucleic Acid Ther."},{"key":"83152_CR69","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1093\/hmg\/9.20.3055","volume":"9","author":"E Serra","year":"2000","unstructured":"Serra, E. et al. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Hum. Mol. Genet. 9, 3055\u20133064 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"83152_CR70","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1471-2164-11-75","volume":"11","author":"L Zhou","year":"2010","unstructured":"Zhou, L., Lim, Q.-E., Wan, G. & Too, H.-P. Normalization with genes encoding ribosomal proteins but not GAPDH provides an accurate quantification of gene expressions in neuronal differentiation of PC12 cells. BMC Genomics 11, 75 (2010).","journal-title":"BMC Genomics"},{"key":"83152_CR71","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/humu.21609","volume":"33","author":"F Piva","year":"2012","unstructured":"Piva, F., Giulietti, M., Burini, A. B. & Principato, G. SpliceAid 2: a database of human splicing factors expression data and RNA target motifs. Hum. Mutat. 33, 81\u201385 (2012).","journal-title":"Hum. Mutat."},{"key":"83152_CR72","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"83152_CR73","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/cyto.a.20022","volume":"58A","author":"E Meijering","year":"2004","unstructured":"Meijering, E. et al. Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry 58A, 167\u2013176 (2004).","journal-title":"Cytometry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83152-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83152-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83152-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:35:44Z","timestamp":1670038544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83152-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83152"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83152-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"8 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3661"}}